Literature DB >> 2012084

Clinical presentation of hemochromatosis: a changing scene.

P C Adams1, A E Kertesz, L S Valberg.   

Abstract

PURPOSE: To investigate the changing modes of clinical presentation and diagnosis in 93 patients with familial hemochromatosis and to compare the results with other reports from 1935 to the present. PATIENTS AND METHODS: The presenting features and the frequency of signs and symptoms were analyzed in 93 homozygotes from 56 families.
RESULTS: Hemochromatosis was detected by chance in 40% of the 56 probands. Abdominal pain (16%), joint pains (11%), and weakness (9%) were prominent features that brought the patient to the physician. Although 38% of the male patients had loss of libido and impotence, these were not identified as presenting features. Features of liver disease (84%), arthritis (11%), and diabetes (2%) led the physician to the diagnosis. Impotence and testicular atrophy were notable, by their absence, in alerting physicians to the presence of hemochromatosis. Screening of family members led to the detection of 37 homozygotes, of whom 46% were asymptomatic. Among this group, arthropathy and gonadal failure were the most common symptoms. The classic triad of hepatomegaly, diabetes, and pigmentation was present in only 8% of patients. Clinical features were rare in patients with less than 5 g of exchangeable body iron and invariably present in those with more than 16 g.
CONCLUSION: The presenting clinical features of hemochromatosis have changed since the original description of the disease in 1935. Family studies have led to the earlier discovery of more homozygous women and earlier detection with less iron loading and, as a result, fewer signs and symptoms.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2012084

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  17 in total

Review 1.  The Art and Science of Diagnosing and Treating Lung and Heart Disease Secondary to Liver Disease.

Authors:  David S Goldberg; Michael B Fallon
Journal:  Clin Gastroenterol Hepatol       Date:  2015-04-28       Impact factor: 11.382

Review 2.  Serum hepcidin concentrations and type 2 diabetes.

Authors:  Alex Aregbesola; Sari Voutilainen; Jyrki K Virtanen; Adeola Aregbesola; Tomi-Pekka Tuomainen
Journal:  World J Diabetes       Date:  2015-07-10

Review 3.  Antagonistic pleiotropy, mutation accumulation, and human genetic disease.

Authors:  R L Albin
Journal:  Genetica       Date:  1993       Impact factor: 1.082

4.  Mineralocorticoid status and endocrine dysfunction in severe hemochromatosis.

Authors:  L M Hempenius; P S Van Dam; J J Marx; H P Koppeschaar
Journal:  J Endocrinol Invest       Date:  1999-05       Impact factor: 4.256

Review 5.  Hereditary hemochromatosis and diabetes mellitus: implications for clinical practice.

Authors:  Kristina M Utzschneider; Kris V Kowdley
Journal:  Nat Rev Endocrinol       Date:  2010-01       Impact factor: 43.330

Review 6.  Liver cirrhosis and diabetes: risk factors, pathophysiology, clinical implications and management.

Authors:  Diego Garcia-Compean; Joel Omar Jaquez-Quintana; Jose Alberto Gonzalez-Gonzalez; Hector Maldonado-Garza
Journal:  World J Gastroenterol       Date:  2009-01-21       Impact factor: 5.742

7.  Contribution of anti-cyclic citrullinated peptide antibody and rheumatoid factor to the diagnosis of arthropathy in haemochromatosis.

Authors:  E Aigner; I Schmid; C H Osterreicher; J Zwerina; G Schett; M Strasser; F Niksic; F Hohla; T Ramsauer; U Dorn; W Patsch; C Datz
Journal:  Ann Rheum Dis       Date:  2007-04-24       Impact factor: 19.103

8.  Intrafamilial variation in hereditary hemochromatosis.

Authors:  P C Adams
Journal:  Dig Dis Sci       Date:  1992-03       Impact factor: 3.199

9.  Clinical manifestations of hemochromatosis in HFE C282Y homozygotes identified by screening.

Authors:  Gordon D McLaren; Christine E McLaren; Paul C Adams; James C Barton; David M Reboussin; Victor R Gordeuk; Ronald T Acton; Emily L Harris; Mark R Speechley; Phyliss Sholinsky; Fitzroy W Dawkins; Beverly M Snively; Thomas M Vogt; John H Eckfeldt
Journal:  Can J Gastroenterol       Date:  2008-11       Impact factor: 3.522

10.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.

Authors:  Douglas B Kell
Journal:  BMC Med Genomics       Date:  2009-01-08       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.